15Oct 2019

A REVIEW OF HALOPERIDOL INDUCED NEUROLOGICAL COMPLICATIONS

  • Doctor of Pharmacy, Chaitanya College of Pharmacy Education and Research, Department Of Pharmacy Practice, Affiliated To Kakatiya University, Warangal, Telangana, India
  • Amrutha Childrens Hospital, Warangal, Telangana, India
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Haloperidol is a known antipsychotic that is administered in the treatment of neurological conditions such as hallucinations, mild to severe psychosis, agitated schizophrenia and other conditions related to mental impairment. As with most drugs, it possesses adverse effects seen in the use of most antipsychotics such as extrapyramidal symptoms or accidental haloperidol symptoms (some of which include tremors, dystonia, and myoclonus disorders), and other neurological complications such as seizures, parkinson?s disease, obsessive compulsive symptoms (OCS) and neuroleptic malignant syndrome (NMS). This review consists of a base study of a seizure case (which occurred as a result of accidental haloperidol poisoning), and a compilation of examined cases which detail the neurological complications associated with the use of haloperidol and antipsychotics in general, such as laryngeal dystonia, rhabdomyolysis associated seizures, etc

  1. Nasrallah, Henry A.; Chen, Alexander T. (August 2017). "Multiple neurotoxic effects of haloperidol resulting in neuronal death". Annals of Clinical Psychiatry. 29 (3): 195?202
  2. Ballard, Clive; Lana, Marisa Margallo; Theodoulou, Megan; Douglas, Simon; McShane, Rupert; Jacoby, Robin; Kossakowski, Katja; Yu, Ly-Mee; Juszczak, Edmund; did a study on A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial).
  3. Schuckit, MA (27 November 2014). "Recognition and management of withdrawal delirium (delirium tremens)". The New England Journal of Medicine. Pg. 371
  4. Jeste, Dilip V. (2011). Clinical handbook of schizophrenia (Pbk. ed.). New York: Guilford Press. p.?511
  5. Mona P Gagre did a study on Accidental Haloperidol poisoning in Children. Department of Pediatrics LTMMC Mumbai. July 31, 2011.
  6. Mohammed K T Salim did a study on Manifestation of Extrapyramidal symptom and seizure in accidental haloperidol ingestion. Kerala University of health sciences. July 12, 2018.
  7. Salisu A. Aikoye et al did a study on intravenous haldol induced seizures in an agitated patient on scheduled low dose response. Department of Psychology CMU, USA. 30 January 2018.
  8. Apollo James et al have done a study on haloperidol induced parkinsonism and its management. Department of Pharmacy Practice, Nanda College of Pharmacy, Tamil Nadu, India.
  9. Kazufumi Yanginuma et al have done a study on Haloperidol Induced Dystonia due to sedation for upper Gastrointestinal endoscopy; A pediatric case report. Department of Pediatrics, Fukisima medical university. 27 March 2019.
  10. Atay Vicral et al, have done a study on myoclonus induced by haloperidol in the intensive care unit. Department of Neuropsychiatry. July 1 2012.
  11. F.P.M did a study on a patient with Haloperidol Induced Layngeal Dystonia. Department of Anesthesiology. University Teaching Hospital. Holland.
  12. Hemanta Dutta et al, did a study on A case of rhabdomyolysis following haloperidol induced seizures. Department of Psychiatry, LGB Institute of health. Assam, India.
  13. korthickeyan et al did a study on Haloperidol Induced Extrapyrimidal Symptoms. Department of Pharmacy. SRM college, Tamil Nadu.
  14. Deepathi Dixit et al have done a study on Neuroleptic Malignant Syndrome associated with haloperidol use in healthcare setting. July 12, 2015.
  15. Uhaq have done a study on Haloperidol Obsessive Compulsive Symptom in a patient with learning disability and bipolar affective disorder. 9 March 2012.
  16. Giannini, A. James; Eighan, Michael S.; Loiselle, Robert H.; Giannini, Matthew C. (1984). "Comparison of Haloperidol and Chlorpromazine in the Treatment of Phencyclidine Psychosis". The Journal of Clinical Pharmacology. 24 (4): 202?4.
  17. Seeman, P; Tallerico, T (1998). "Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors". Molecular Psychiatry. 3 (2): 123?34.
  18. Schotte, A; Janssen PF; Megens AA; Leysen JE (1993). "Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
  19. Leysen, JE; Janssen, PM; Megens, AA; Schotte, A (1994). "Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity". The Journal of Clinical Psychiatry. 55 (Suppl): 5?12.
  20. Cobos, Enrique J.; Del Pozo, Esperanza; Baeyens, Jos? M. (2007). "Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells". Journal of Neurochemistry. 102 (3): 812?25.
  21. Kroeze, Wesley K; Hufeisen, Sandra J; Popadak, Beth A; Renock, Sean M; Steinberg, Seanna; Ernsberger, Paul; Jayathilake, Karu; Meltzer, Herbert Y; Roth, Bryan L (2003). "H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs". Neuropsychopharmacology. 28 (3): 519?26.
  22. Ilyin, VI; Whittemore, ER; Guastella, J; Weber, E; Woodward, RM (1996). "Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol". Molecular Pharmacology. 50 (6): 1541?50.
  23. Kornhuber, Johannes; Schultz, Andreas; Wiltfang, Jens; Meineke, Ingolf; Gleiter, Christoph H.; Z?chling, Robert; Boissl, Karl-Werner; Leblhuber, Friedrich; Riederer, Peter (1999). "Persistence of Haloperidol in Human Brain Tissue". The American Journal of Psychiatry. 156 (6): 885?90.
  24. Lopez-Munoz, Francisco; Alamo, Cecilio (2009). "The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice". Brain Research Bulletin. 79 (2): 130?141.
  25. Oosthuizen, P.; Emsley, R. A.; Turner, J.; Keyter, N. (2001). "Determining the optimal dose of haloperidol in first-episode psychosis". Journal of Psychopharmacology. 15 (4): 251?5.

[Yata vijaya and Okeke chukwugoziem bright (2019); A REVIEW OF HALOPERIDOL INDUCED NEUROLOGICAL COMPLICATIONS Int. J. of Adv. Res. 7 (Oct). 1359-1364] (ISSN 2320-5407). www.journalijar.com

Vijaya Yata

DOI:

Article DOI: 10.21474/IJAR01/9965      
DOI URL: http://dx.doi.org/10.21474/IJAR01/9965

Download Full Paper

Download PDF No. of Downloads: 31 | No. of Views: 151